Stock UniverseDerived research view · source repositories remain read-only

Innate Pharma S.A. (IPHA)

Therapeutics / Biopharma · Healthcare / Biotechnology
Score Band
Speculative
Selection Score
21.48
Global Rank
3173
Market Cap
162.13M
Latest Close
1.71
RS Composite
-0.45% · G#1395

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
13.25%
3M
6.87%
6M
-10.00%
1Y
-20.09%
3Y
-41.84%
5Y
-56.27%
10Y
-71.74%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 5.55K · 30-day average: 113.16K · Max drawdown over stored range: -85.73%

Research Snapshot

Relative Strength vs SPX

RS Composite-0.45%
20D RS24.18%
60D RS1.35%
120D RS-14.56%
Global RS Rank1395 · 58.42% percentile
Watch+Speculative RS Rank897 · 57.22% percentile
Group ScopeWatch+Speculative
Primary RS Rank134 · 70.74% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank408 / 701
Primary Percentile41.94
Score Notesmarket-cap support, industry-tailwind, microcap penalty

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

No processed TTM rows for IPHA.

TTM Valuation

No SEC TTM valuation available.

Financial Statement Metrics

MetricFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue69.77324.70357.67461.64120.1219.005
Revenue Growth (YoY)-18.345%-64.595%133.47%6.878%-67.358%-55.246%
Gross Profit20.065-22.3016.0115.619-31.859
Operating Income1.079-47.825-16.425-12.669-51.575
Free Cash Flow-52.674-59.386-19.69-32.91-7.287-52.895
Free Cash Flow Per Share-0.667-0.747-0.247-0.409-0.09-0.590405
EPS (Diluted) GAAP-0.810591-0.663908-0.731644-0.094091-0.610362
EPS Growth
EPS Non-GAAP
Gross Margin28.758%-90.276%10.422%9.116%-158.337%100%
Operating Margin1.546%-193.6%-28.479%-20.553%-256.324%-599.756%
Profit Margin-91.703%-213.776%-100.744%-12.281%-245.868%-546.108%
Free Cash Flow Margin-75.493%-240.4%-34.14%-53.39%-36.216%-587.396%
Shares Outstanding (Diluted)78.93579.542679.639880.453381.051889.591
Shares Change (YoY)17.975%0.77%0.122%1.021%0.744%10.535%

SEC Quarterly Fundamentals

No processed quarterly rows for IPHA.